Citations

Clear

8 citation(s) found for "Chen, Hai".

Germline regulation of tumor evolutionary dynamics shapes multiple myeloma progression
Chen, Hai, Shu, Jingmin, Wang, Panwen , Bergsagel, Leif, Yang, Ping, Shi, Changxin, Liu, Li, Mudappathi, Rekha , Liu, Li , Chen, Hai, Bergsagel, P. Leif , Sun, Zhifu

Mayo Clinic

No container title available | June 7, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.06.05.730550 | PMID 42282549 Get It

ABSTRACT Germline variation shapes cancer risk, yet its influence on the evolutionary dynamics of established tumors remains poorly understood. In multiple myeloma, subclonal diversification drives disease progression and treatment failure, but the heritable factors that modulate this process are unknown. Here, we show that germline variation is associated with tumor evolutionary features, implicating inherited regulation in subclonal expansion. Integrating germline variation with tumor evolutionary parameters identifies variants associated with evolutionary features, with signals enriched in regulatory regions, consistent with a transcriptional basis. We further identify TBKBP1 as a key locus linking germline variation to tumor evolution and clinical outcome. Germline variation at this locus is associated with TBKBP1 expression and subclonal expansion, and TBKBP1 expression correlates with adverse prognosis, consistent across independent cohorts. Functional analyses demonstrate that TBKBP1 promotes proliferation and activates MYC, mTORC1 and non-canonical NF-κB signaling pathway. Together, these findings establish germline regulatory variation as a determinant of tumor evolutionary dynamics and identify TBKBP1 as a mediator linking inherited variation to subclonal expansion and disease progression in multiple myeloma.
Competing subclones and fitness diversity shape tumor evolution across cancer types
Chen, Hai, Shu, Jingmin, Li, Elaine, Wang, Panwen , Bergsagel, L., Yang, Ping, Sun, Z, Zhao, Logan, Shi, Changxin, Townsend, Jeffrey P, Liu, Li, Yang, Ping , Mudappathi, Rekha , Bergsagel, Leif, Yang, Ping , Townsend, Jeffrey P , Maley, Carlo C. , Liu, Li , Chen, Hai, Shu, Jingmin, Bergsagel, P. Leif

Mayo Clinic

Bioinformatics | March 11, 2026 | Volume: 42 | Issue: 3 | Pages: No page available

10.1093/bioinformatics/btag127 | PMID 41826799 Get It

Abstract Motivation Intratumor heterogeneity arises from ongoing somatic evolution and complicates cancer diagnosis, prognosis, and treatment. Reconstructing evolutionary dynamics typically requires spatiotemporal samples, which are often unavailable in clinical settings. Computational approaches that can infer tumor evolutionary history from single-timepoint bulk sequencing data remain limited. Results We present estimating evolutionary events through single-timepoint sequencing (TEATIME), a novel computational framework that models tumors as mixtures of two competing cell populations: an ancestral clone with baseline fitness and a derived subclone with elevated fitness. Using cross-sectional bulk sequencing data, TEATIME estimates mutation rates, timing of subclone emergence, relative fitness, and number of generations of growth. To quantify intratumor fitness asymmetries, we introduce a novel metric—fitness diversity—which captures the imbalance between competing cell populations and serves as a measure of functional intratumor heterogeneity. Applying TEATIME to 33 tumor types from The Cancer Genome Atlas, we revealed divergent as well as convergent evolutionary patterns. Notably, we found that immune-hot microenvironments constraint subclonal expansion and limit fitness diversity. Moreover, we detected temporal dependencies in mutation acquisition, where early driver mutations in ancestral clones epistatically shape the fitness landscape, predisposing specific subclones to selective advantages. These findings underscore the importance of intratumor competition and tumor-microenvironment interactions in shaping evolutionary trajectories, driving intratumor heterogeneity. Lastly, we demonstrate that TEATIME-derived evolutionary parameters and fitness diversity offer novel prognostic insights across multiple cancer types. Availability and implementation R implementation of TEATIME is available on GitHub (https://github.com/liliulab/TEATIME) and Zenodo (https://zenodo.org/records/17422174).
Competing Subclones and Fitness Diversity Shape Tumor Evolution Across Cancer Types
Chen, Hai , Shu, Jingmin, Li, Elaine, Wang, Panwen , Bergsagel, Leif, Sun, Zhifu, Zhao, Logan, Bergsagel, P. Leif , Bergsagel, P. Leif , Mudappathi, Rekha , Shi, Changxin, Liu, Li , Chen, Hai, Shu, Jingmin, Bergsagel, L., Sun, Z, Zhao, Logan, Maley, Carlo C.

Mayo Clinic

No container title available | June 4, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2025.05.31.657191 | PMID 40502073 Get It

ABSTRACT Intratumor heterogeneity arises from ongoing somatic evolution complicating cancer diagnosis, prognosis, and treatment. Here we present TEATIME (es t imating e volution a ry events t hrough s i ngle-ti m epoint s e quencing), a novel computational framework that models tumors as mixtures of two competing cell populations: an ancestral clone with baseline fitness and a derived subclone with elevated fitness. Using cross-sectional bulk sequencing data, TEATIME estimates mutation rates, timing of subclone emergence, relative fitness, and number of generations of growth. To quantify intratumor fitness asymmetries, we introduce a novel metric—fitness diversity—which captures the imbalance between competing cell populations and serves as a measure of functional intratumor heterogeneity. Applying TEATIME to 33 tumor types from The Cancer Genome Atlas, we revealed divergent as well as convergent evolutionary patterns. Notably, we found that immune-hot microenvironments constraint subclonal expansion and limit fitness diversity. Moreover, we detected temporal dependencies in mutation acquisition, where early driver mutations in ancestral clones epistatically shape the fitness landscape, predisposing specific subclones to selective advantages. These findings underscore the importance of intratumor competition and tumor-microenvironment interactions in shaping evolutionary trajectories, driving intratumor heterogeneity. Lastly, we demonstrate that TEATIME-derived evolutionary parameters and fitness diversity offer novel prognostic insights across multiple cancer types.
Determinants of the Repetitive-CMAP Occurrence and Therapy Efficacy in Slow-Channel Myasthenia (1253)
Di, Li , Chen, Hai , Selcen, Duygu , Engel, Andrew, Da, Yuwei , Shen, Xin‐Ming , Di, Li, Lü, Yan

Mayo Clinic

Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.96.15_supplement.1253 Get It

Determinants of the repetitive-CMAP occurrence and therapy efficacy in slow-channel myasthenia
Di, Li , Chen, Hai , Selcen, Duygu , Engel, Andrew G. , Da, Yuwei , Shen, Xin‐Ming , Shen, Xin-Ming , Di, Li, Lü, Yan

Mayo Clinic

Neurology | September 10, 2020 | Volume: 95 | Issue: 20 | Pages: No page available

10.1212/wnl.0000000000010734 | PMID 32907971 Get It

Microarray Analysis on Gene Regulation by Estrogen, Progesterone and Tamoxifen in Human Endometrial Stromal Cells
Ren, Chun-E, Li, Jin‐Ping , Lyle, Christian, Dowdy, Sean C. , Podratz, Karl C. , Byck, David, Chen, Hai-Bin, Jiang, Shi-Wen, Chen, Hai-Bin , Dowdy, Sean, Zhu, Xueqiong , Jiang, Shi‐Wen

Mayo Clinic

International Journal of Molecular Sciences | March 13, 2015 | Volume: 16 | Issue: 3 | Pages: 5864-5885

10.3390/ijms16035864 | PMID 25782154 Get It

Epithelial stromal cells represent a major cellular component of human uterine endometrium that is subject to tight hormonal regulation. Through cell-cell contacts and/or paracrine mechanisms, stromal cells play a significant role in the malignant transformation of epithelial cells. We isolated stromal cells from normal human endometrium and investigated the morphological and transcriptional changes induced by estrogen, progesterone and tamoxifen. We demonstrated that stromal cells express appreciable levels of estrogen and progesterone receptors and undergo different morphological changes upon hormonal stimulation. Microarray analysis indicated that both estrogen and progesterone induced dramatic alterations in a variety of genes associated with cell structure, transcription, cell cycle, and signaling. However, divergent patterns of changes, and in some genes opposite effects, were observed for the two hormones. A large number of genes are identified as novel targets for hormonal regulation. These hormone-responsive genes may be involved in normal uterine function and the development of endometrial malignancies.
HE4 Transcription- and Splice Variants-Specific Expression in Endometrial Cancer and Correlation with Patient Survival
Jiang, Shi-Wen, Chen, Hai-Bin , Dowdy, Sean C. , Fu, Alex Z., Attewell, John R., Kalogera, Eleftheria , Drapkin, Ronny , Podratz, Karl C. , Broaddus, Russell R. , Li, Jinping , Jiang, Shi‐Wen , Drapkin, Ronny

Mayo Clinic

International Journal of Molecular Sciences | November 19, 2013 | Volume: 14 | Issue: 11 | Pages: 22655-22677

10.3390/ijms141122655 | PMID 24252907 Get It

We investigated the HE4 variant-specific expression patterns in various normal tissues as well as in normal and malignant endometrial tissues. The relationships between mRNA variants and age, body weight, or survival are analyzed. ICAT-labeled normal and endometrial cancer (EC) tissues were analyzed with multidimensional liquid chromatography followed by tandem mass spectrometry. Levels of HE4 mRNA variants were measured by real-time PCR. Mean mRNA levels were compared among 16 normal endometrial samples, 14 grade 1 and 14 grade 3 endometrioid EC, 15 papillary serous EC, and 14 normal human tissue samples. The relationship between levels of HE4 variants and EC patient characteristics was analyzed with the use of Pearson correlation test. We found that, although all five HE4 mRNA variants are detectable in normal tissue samples, their expression is highly tissue-specific, with epididymis, trachea, breast and endometrium containing the highest levels. HE4-V0, -V1, and -V3 are the most abundant variants in both normal and malignant tissues. All variants are significantly increased in both endometrioid and papillary serous EC, with higher levels observed in grade 3 endometrioid EC. In the EC group, HE4-V1, -V3, and -V4 levels inversely correlate with EC patient survival, whereas HE4-V0 levels positively correlate with age. HE4 variants exhibit tissue-specific expression, suggesting that each variant may exert distinct functions in normal and malignant cells. HE4 levels appear to correlate with EC patient survival in a variant-specific manner. When using HE4 as a biomarker for EC management, the effects of age should be considered.
HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell Lines
Li, Jinping , Mariani, Andrea , Chen, Dong , Klatt, Edward, Podratz, Karl C. , Drapkin, Ronny , Broaddus, Russell R. , Dowdy, Sean C. , Jiang, Shi‐Wen , Chen, Hai-Bin , Chen, Haibin , Klatt, Edward, Chen, Dong , Drapkin, Ronny

Mayo Clinic

International Journal of Molecular Sciences | March 15, 2013 | Volume: 14 | Issue: 3 | Pages: 6026-6043

10.3390/ijms14036026 | PMID 23502467 Get It

HE4, also known as WFDC2, is a useful biomarker for ovarian cancer when either used alone or in combination with CA125. HE4 is also overexpressed in endometrial cancer (EC), but its function in cancer cells is not clear. In this study, we investigate the role of HE4 in EC progression. An HE4-overexpression system was established by cloning the HE4 prototypic mRNA variant (HE4-V0) into a eukaryotic expression vector. Following transfection, stable clones in two EC cell lines were selected. The effects of HE4 overexpression on cell growth and function were measured with the use of cell proliferation assay, matrigel invasion, and soft agar gel colony formation assays. HE4-induced cancer cell proliferation in vivo was examined in a mouse xenograft model. HE4 overexpression significantly enhanced EC cell proliferation, matrigel invasion, and colony formation in soft agar. Moreover, HE4 overexpression promoted tumor growth in the mouse xenograft model. HE4 overexpression enhanced several malignant phenotypes in cell culture and in a mouse model. These results are consistent with our previous observation that high levels of serum HE4 closely correlate with the stage, myometrial invasion and tumor size in patients with EC. This study provides evidence that HE4 overexpression directly impacts tumor progression in endometrial cancer.